Last 47 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -5.22 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 49.04 | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -41.3% | — | — | — | |
| P/S Ratio | 0.38 | 0.44 | 0.59 | 0.69 | 0.71 | 0.54 | 0.83 | 0.78 | 0.76 | 0.63 | 0.73 | 0.63 | 0.65 | 0.89 | 0.85 | 0.85 | 0.84 | 1.00 | 1.53 | 1.23 | 1.68 |
| — | -18.3% | -28.6% | -12.0% | -7.4% | -14.6% | +13.6% | +25.1% | +17.5% | -28.5% | -15.0% | -26.2% | -22.7% | -11.5% | -44.1% | -31.3% | -49.8% | -39.1% | -23.7% | -30.3% | +23.2% | |
| P/B Ratio | 0.70 | 0.87 | 1.07 | 1.35 | 1.32 | 0.96 | 1.40 | 1.34 | 1.14 | 0.92 | 0.96 | 0.84 | 0.78 | 1.04 | 0.90 | 1.23 | 1.15 | 1.38 | 1.94 | 1.83 | 2.07 |
| — | -9.3% | -23.6% | +0.3% | +15.1% | +4.1% | +45.2% | +60.2% | +46.9% | -11.0% | +6.6% | -31.9% | -32.4% | -25.1% | -53.5% | -32.8% | -44.3% | -37.3% | -18.7% | -21.6% | +21.4% | |
| P/FCF | — | — | — | 8.61 | 58.26 | 24.31 | — | 11.11 | 25.65 | — | — | — | — | — | — | — | — | — | — | 31.07 | 54.72 |
| — | — | — | -22.6% | +127.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +166.9% | +570.9% | |
| EV / EBITDA | 4.47 | 30.92 | — | 1.83 | — | 72.66 | — | 12.17 | — | — | — | — | — | — | — | — | 34.72 | 7.80 | 28.60 | — | 22.51 |
| — | -57.5% | — | -84.9% | — | — | — | — | — | — | — | — | — | — | — | — | +54.3% | -46.6% | -20.0% | — | +132.1% | |
| EV / EBIT | — | — | — | 87.27 | — | — | — | — | — | — | — | — | — | — | — | — | — | 31.47 | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -11.5% | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.1% | 71.0% | 70.9% | 64.6% | 72.2% | 68.7% | 62.8% | 69.0% | 68.7% | 67.8% | 67.5% | 68.2% | 65.1% | 63.9% | 63.0% | 73.0% | 73.2% | 73.2% | 73.4% | 73.4% | 74.8% |
| — | +3.3% | +13.0% | -6.4% | +5.1% | +1.3% | -6.9% | +1.2% | +5.5% | +6.1% | +7.1% | -6.6% | -11.1% | -12.7% | -14.2% | -0.6% | -2.2% | -5.4% | -2.7% | -2.5% | -2.0% | |
| Operating Margin | -8.3% | -3.9% | -7.0% | 6.1% | -8.3% | -7.9% | -25.2% | -5.3% | -9.6% | -12.5% | -15.6% | -9.1% | -13.3% | -19.6% | -34.1% | -9.0% | -5.1% | 5.6% | -2.9% | -7.5% | -0.3% |
| — | +51.1% | +72.4% | +214.9% | +13.8% | +37.2% | -62.3% | +41.8% | +27.7% | +36.0% | +54.4% | -1.1% | -161.7% | -448.2% | -1078.4% | -20.8% | -1723.5% | +60.0% | -4.7% | -337.4% | -107.4% | |
| Net Margin | -11.2% | -7.5% | -10.6% | -1.0% | -11.1% | -6.9% | -27.4% | -13.5% | -13.9% | -16.8% | -19.1% | -11.1% | -15.7% | -21.1% | -34.8% | -5.8% | -9.4% | 2.1% | -4.2% | -26.2% | -1.9% |
| — | -8.0% | +61.2% | +92.5% | +20.4% | +58.8% | -43.6% | -22.2% | +11.2% | +20.1% | +45.1% | -91.5% | -66.8% | -1100.0% | -729.9% | +78.0% | -386.8% | +5.7% | +23.9% | -229.1% | -146.0% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -19.3% | -3.7% | -4.7% | -0.5% | -5.1% | -3.1% | -11.0% | -5.7% | -5.1% | -6.0% | -6.2% | -3.7% | -4.6% | -6.0% | -12.2% | -2.1% | -3.2% | 0.7% | -1.3% | -9.4% | -0.6% |
| — | -19.0% | +57.2% | +91.2% | +1.0% | +48.7% | -79.2% | -55.1% | -11.2% | +0.9% | +49.4% | -73.4% | -44.9% | -923.0% | -817.9% | +77.5% | -431.3% | +8.9% | +18.8% | -254.9% | -144.9% | |
| ROA | -10.6% | -1.8% | -2.4% | -0.3% | -2.7% | -1.7% | -6.2% | -3.3% | -3.1% | -3.7% | -3.9% | -2.4% | -3.2% | -4.3% | -8.9% | -1.6% | -2.4% | 0.5% | -1.0% | -6.7% | -0.4% |
| — | -5.9% | +61.1% | +92.0% | +12.8% | +54.7% | -57.3% | -36.7% | +2.0% | +13.7% | +55.6% | -55.8% | -35.8% | -904.7% | -832.2% | +76.8% | -442.9% | +13.1% | +15.1% | -273.5% | -151.8% | |
| ROIC | -8.6% | -1.1% | -1.8% | 1.7% | -2.2% | -2.0% | -6.1% | -1.4% | -2.2% | -2.8% | -3.2% | -2.0% | -2.7% | -4.0% | -9.1% | -2.7% | -1.4% | 1.7% | -0.8% | -2.4% | -0.1% |
| — | +45.4% | +70.9% | +222.6% | +1.3% | +27.8% | -90.4% | +31.2% | +18.2% | +30.2% | +64.4% | +25.3% | -87.1% | -335.7% | -996.1% | -12.0% | -1764.8% | +56.0% | -7.7% | -354.8% | -107.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.51 | 0.55 | 0.54 | 0.51 | 0.46 | 0.45 | 0.42 | 0.36 | 0.26 | 0.25 | 0.24 | 0.20 | 0.15 | 0.14 | 0.10 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | 0.06 |
| — | +22.4% | +28.1% | +42.7% | +77.1% | +78.2% | +74.8% | +82.6% | +79.6% | +75.3% | +146.9% | +206.0% | +141.7% | +142.1% | +60.8% | -11.4% | -3.0% | -5.9% | -5.7% | +3.3% | -4.2% | |
| Debt / EBITDA | 15.51 | 57.49 | — | 2.23 | — | 102.68 | — | 11.33 | — | — | — | — | — | — | — | — | 7.90 | 1.45 | 3.88 | — | 2.94 |
| — | -44.0% | — | -80.3% | — | — | — | — | — | — | — | — | — | — | — | — | +169.2% | -18.9% | -7.7% | — | +80.4% | |
| Current Ratio | 2.45 | 2.84 | 2.87 | 2.45 | 2.47 | 2.67 | 2.71 | 2.57 | 2.39 | 2.48 | 2.65 | 2.54 | 2.58 | 2.82 | 2.98 | 3.06 | 3.18 | 3.15 | 2.89 | 2.55 | 3.25 |
| — | +6.5% | +5.8% | -4.8% | +3.4% | +7.8% | +2.2% | +1.0% | -7.6% | -12.1% | -11.1% | -16.9% | -18.8% | -10.5% | +3.1% | +20.2% | -2.2% | -0.6% | +8.8% | -2.1% | +19.3% | |
| Quick Ratio | 2.24 | 1.67 | 1.76 | 1.43 | 1.38 | 1.50 | 1.50 | 1.45 | 1.11 | 1.13 | 1.19 | 1.20 | 1.13 | 1.25 | 1.37 | 1.86 | 1.89 | 1.95 | 1.88 | 1.76 | 2.19 |
| — | +11.0% | +17.6% | -0.8% | +23.6% | +33.1% | +25.4% | +20.5% | -1.2% | -9.5% | -12.7% | -35.6% | -40.3% | -36.0% | -27.5% | +5.7% | -13.9% | -10.1% | +4.2% | -1.4% | +19.2% | |
| Interest Coverage | -4.19 | -1.21 | -2.68 | 0.50 | -3.76 | -2.60 | -10.57 | -0.99 | -4.11 | -5.55 | -6.72 | -3.90 | -17.01 | -28.95 | -45.80 | -29.51 | -32.83 | 8.47 | -10.70 | -20.98 | -4.85 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying OFIX stock.
Orthofix Medical Inc.'s current P/E is -5.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Orthofix Medical Inc.'s current operating margin is -8.3%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Orthofix Medical Inc.'s business trajectory between earnings reports.